Aurora Cannabis Inc. (ACB)
Market Cap | 211.67M |
Revenue (ttm) | 219.84M |
Net Income (ttm) | -32.33M |
Shares Out | 54.84M |
EPS (ttm) | -0.62 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 755,258 |
Open | 4.000 |
Previous Close | 3.960 |
Day's Range | 3.840 - 4.040 |
52-Week Range | 2.840 - 9.350 |
Beta | 2.70 |
Analysts | Hold |
Price Target | n/a |
Earnings Date | Feb 6, 2025 |
About ACB
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, ... [Read more]
Financial Performance
In 2023, Aurora Cannabis's revenue was 270.28 million, an increase of 20.77% compared to the previous year's 223.80 million. Losses were -65.58 million, -91.97% less than in 2022.
Financial numbers in CAD Financial StatementsNews
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are p...
Empowering the Next Generation: Aurora Announces German Internship Program
NASDAQ | TSX: ACB Company Launches Internships at Manufacturing Facility in Leuna, Germany to Cultivate Future Leaders in the Medical Cannabis Industry EDMONTON, AB , Jan. 10, 2025 /PRNewswire/ - Auro...
Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by ...
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect
NASDAQ | TSX: ACB The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB , Dec. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (T...
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time hig...
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), th...
Marijuana Industry Could Stay in Limbo Under Trump
A hands-off policy on cannabis will be a bad outcome for a business already struggling with ambiguous laws.
Aurora Cannabis Expands Innovative Recreational Product Portfolio
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), th...
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pre...
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannab...
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
If controversial Republican Matt Gaetz manages to win confirmation as attorney general, his tenure at the Justice Department is expected to be positive for the cannabis industry.
Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say
A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers in the industry, as optimism around the promise of a legal market has faded.
Aurora Cannabis: Buy The Election Overreaction
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora rep...
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Aurora Cannabis Inc. ACB recently reported strong quarterly earnings that outpaced market expectations, despite a downturn across the cannabis sector.
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Donald Trump's presidential election victory Tuesday, the cannabis sector took a sharp downturn.
Cannabis Stocks Plummet After Legalization Bid Fails in Florida
Shares of cannabis companies fell Wednesday after a ballot measure that would have legalized recreational marijuana in Florida failed to pass.
Cannabis stocks crater as Florida fails to garner needed votes for adult use
North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure passed in Nebraska.
Aurora Cannabis Inc. (ACB) Q2 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB) Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - CEO Simona King -...
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results
NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical Cannabis Re-Affirms Target of P...
Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB , Oct. 24, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, ann...
Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch New Oil Products for Enhanced Patient Care Options EDMONTON, AB , Oct. 16, 2024 /CNW/ - Aurora Cannabis Inc.,...
Profit from the Green Wave: Top Cannabis Stocks to Watch
The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at...
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
NASDAQ | TSX: ACB Research Project designed to validate breeding genetics connected with fruity aroma, a key patient and consumer preference trait, with positive impact on future innovation EDMONTON,...